loader
Please Wait
Applying Filters...
menu
    • menu

    Setid 2dbd0671 C565 40c5 Bf0f E324db26799c Applno 203975 Form Powder Inhalation Dosage Eq 0 0625mg Base Inh Eq 0 025mg Base Inh - Drug Product Composition: Vilanterol Trifenatate

    Menu

    Vilanterol Trifenatate

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    DRUG PRODUCT COMPOSITIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    REF. STANDARDS & IMPURITIES

    PharmaCompass
    $ API Ref.Price (USD/KG) : 180,231Xls

    Filters

    clear-filterReset all filters
    SearchXls

    USFDA APPLICATION NUMBER - 203975 / DOSAGE - POWDER;INHALATION - EQ 0.0625MG BASE/INH;EQ 0.025MG BASE/INH

    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    UMECLIDINIUM BROMIDE(UNII: 7AN603V4JV)
    (UMECLIDINIUM - UNII:GE2T1418SV)     		UMECLIDINIUM62.5ug
    VILANTEROL TRIFENATATE(UNII: 40AHO2C6DG)
    (VILANTEROL - UNII:028LZY775B)     		VILANTEROL25ug

    Inactive Ingredients

    Ingredient Name
    GlaxoSmithKline LLC
    LACTOSE MONOHYDRATE(EWQ57Q8I5X)
    MAGNESIUM STEARATE(70097M6I30)